|
nasdaq:edap
|
1296557
|
Apr 21st, 2024 12:00AM
|
EDAP TMS
|
5.3K
|
202.00
|
Open
|
|
Apr 20th, 2024 11:22PM
|
Apr 20th, 2024 11:22PM
|
EDAP TMS is a high-tech medical company listed on the Nasdaq (EDAP) which develops, manufactures and markets minimally invasive medical devices using ultrasound technology for various medical applications and offers a wide portfolio of complementary distribution products in urology.
By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion.
As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems.
EDAP TMS is listed on NASDAQ market in New York under ticker symbol “EDAP”.
|
Open
|
Medical Device, Prostate Cancer, HIFU, ESWL, Urology, Therapeutic Ultrasound, Urinary stones, and Research & Development
|
Open
|
4 Rue du Dauphine
|
Vaulx-en-Velin
|
Auvergne-Rhône-Alpes
|
FR
|
69120
|
|
EDAP TMS
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:edap
|
1296557
|
Apr 20th, 2024 12:00AM
|
EDAP TMS
|
5.3K
|
202.00
|
Open
|
|
Apr 19th, 2024 11:19PM
|
Apr 20th, 2024 04:55PM
|
EDAP TMS is a high-tech medical company listed on the Nasdaq (EDAP) which develops, manufactures and markets minimally invasive medical devices using ultrasound technology for various medical applications and offers a wide portfolio of complementary distribution products in urology.
By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion.
As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems.
EDAP TMS is listed on NASDAQ market in New York under ticker symbol “EDAP”.
|
Open
|
Medical Device, Prostate Cancer, HIFU, ESWL, Urology, Therapeutic Ultrasound, Urinary stones, and Research & Development
|
Open
|
4 Rue du Dauphine
|
Vaulx-en-Velin
|
Auvergne-Rhône-Alpes
|
FR
|
69120
|
|
EDAP TMS
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:edap
|
1296557
|
Apr 19th, 2024 12:00AM
|
EDAP TMS
|
5.3K
|
202.00
|
Open
|
|
Apr 18th, 2024 11:26PM
|
Apr 18th, 2024 11:26PM
|
EDAP TMS is a high-tech medical company listed on the Nasdaq (EDAP) which develops, manufactures and markets minimally invasive medical devices using ultrasound technology for various medical applications and offers a wide portfolio of complementary distribution products in urology.
By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion.
As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems.
EDAP TMS is listed on NASDAQ market in New York under ticker symbol “EDAP”.
|
Open
|
Medical Device, Prostate Cancer, HIFU, ESWL, Urology, Therapeutic Ultrasound, Urinary stones, and Research & Development
|
Open
|
4 Rue du Dauphine
|
Vaulx-en-Velin
|
Auvergne-Rhône-Alpes
|
FR
|
69120
|
|
EDAP TMS
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:edap
|
1296557
|
Apr 18th, 2024 12:00AM
|
EDAP TMS
|
5.3K
|
202.00
|
Open
|
|
Apr 17th, 2024 11:34PM
|
Apr 18th, 2024 06:15PM
|
EDAP TMS is a high-tech medical company listed on the Nasdaq (EDAP) which develops, manufactures and markets minimally invasive medical devices using ultrasound technology for various medical applications and offers a wide portfolio of complementary distribution products in urology.
By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion.
As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems.
EDAP TMS is listed on NASDAQ market in New York under ticker symbol “EDAP”.
|
Open
|
Medical Device, Prostate Cancer, HIFU, ESWL, Urology, Therapeutic Ultrasound, Urinary stones, and Research & Development
|
Open
|
4 Rue du Dauphine
|
Vaulx-en-Velin
|
Auvergne-Rhône-Alpes
|
FR
|
69120
|
|
EDAP TMS
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:edap
|
1296557
|
Apr 17th, 2024 12:00AM
|
EDAP TMS
|
5.3K
|
203.00
|
Open
|
|
Apr 16th, 2024 11:17PM
|
Apr 17th, 2024 02:39PM
|
EDAP TMS is a high-tech medical company listed on the Nasdaq (EDAP) which develops, manufactures and markets minimally invasive medical devices using ultrasound technology for various medical applications and offers a wide portfolio of complementary distribution products in urology.
By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion.
As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems.
EDAP TMS is listed on NASDAQ market in New York under ticker symbol “EDAP”.
|
Open
|
Medical Device, Prostate Cancer, HIFU, ESWL, Urology, Therapeutic Ultrasound, Urinary stones, and Research & Development
|
Open
|
4 Rue du Dauphine
|
Vaulx-en-Velin
|
Auvergne-Rhône-Alpes
|
FR
|
69120
|
|
EDAP TMS
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:edap
|
1296557
|
Apr 16th, 2024 12:00AM
|
EDAP TMS
|
5.2K
|
203.00
|
Open
|
|
Apr 15th, 2024 11:13PM
|
Apr 16th, 2024 10:56AM
|
EDAP TMS is a high-tech medical company listed on the Nasdaq (EDAP) which develops, manufactures and markets minimally invasive medical devices using ultrasound technology for various medical applications and offers a wide portfolio of complementary distribution products in urology.
By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion.
As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems.
EDAP TMS is listed on NASDAQ market in New York under ticker symbol “EDAP”.
|
Open
|
Medical Device, Prostate Cancer, HIFU, ESWL, Urology, Therapeutic Ultrasound, Urinary stones, and Research & Development
|
Open
|
4 Rue du Dauphine
|
Vaulx-en-Velin
|
Auvergne-Rhône-Alpes
|
FR
|
69120
|
|
EDAP TMS
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:edap
|
1296557
|
Apr 15th, 2024 12:00AM
|
EDAP TMS
|
5.2K
|
203.00
|
Open
|
|
Apr 14th, 2024 11:08PM
|
Apr 15th, 2024 04:37PM
|
EDAP TMS is a high-tech medical company listed on the Nasdaq (EDAP) which develops, manufactures and markets minimally invasive medical devices using ultrasound technology for various medical applications and offers a wide portfolio of complementary distribution products in urology.
By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion.
As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems.
EDAP TMS is listed on NASDAQ market in New York under ticker symbol “EDAP”.
|
Open
|
Medical Device, Prostate Cancer, HIFU, ESWL, Urology, Therapeutic Ultrasound, Urinary stones, and Research & Development
|
Open
|
4 Rue du Dauphine
|
Vaulx-en-Velin
|
Auvergne-Rhône-Alpes
|
FR
|
69120
|
|
EDAP TMS
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:edap
|
1296557
|
Apr 14th, 2024 12:00AM
|
EDAP TMS
|
5.2K
|
202.00
|
Open
|
|
Apr 13th, 2024 10:57PM
|
Apr 13th, 2024 10:57PM
|
EDAP TMS is a high-tech medical company listed on the Nasdaq (EDAP) which develops, manufactures and markets minimally invasive medical devices using ultrasound technology for various medical applications and offers a wide portfolio of complementary distribution products in urology.
By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion.
As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems.
EDAP TMS is listed on NASDAQ market in New York under ticker symbol “EDAP”.
|
Open
|
Medical Device, Prostate Cancer, HIFU, ESWL, Urology, Therapeutic Ultrasound, Urinary stones, and Research & Development
|
Open
|
4 Rue du Dauphine
|
Vaulx-en-Velin
|
Auvergne-Rhône-Alpes
|
FR
|
69120
|
|
EDAP TMS
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:edap
|
1296557
|
Apr 13th, 2024 12:00AM
|
EDAP TMS
|
5.2K
|
202.00
|
Open
|
|
Apr 12th, 2024 10:48PM
|
Apr 13th, 2024 11:23AM
|
EDAP TMS is a high-tech medical company listed on the Nasdaq (EDAP) which develops, manufactures and markets minimally invasive medical devices using ultrasound technology for various medical applications and offers a wide portfolio of complementary distribution products in urology.
By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion.
As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems.
EDAP TMS is listed on NASDAQ market in New York under ticker symbol “EDAP”.
|
Open
|
Medical Device, Prostate Cancer, HIFU, ESWL, Urology, Therapeutic Ultrasound, Urinary stones, and Research & Development
|
Open
|
4 Rue du Dauphine
|
Vaulx-en-Velin
|
Auvergne-Rhône-Alpes
|
FR
|
69120
|
|
EDAP TMS
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:edap
|
1296557
|
Apr 12th, 2024 12:00AM
|
EDAP TMS
|
5.2K
|
202.00
|
Open
|
|
Apr 11th, 2024 10:53PM
|
Apr 12th, 2024 08:18AM
|
EDAP TMS is a high-tech medical company listed on the Nasdaq (EDAP) which develops, manufactures and markets minimally invasive medical devices using ultrasound technology for various medical applications and offers a wide portfolio of complementary distribution products in urology.
By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion.
As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems.
EDAP TMS is listed on NASDAQ market in New York under ticker symbol “EDAP”.
|
Open
|
Medical Device, Prostate Cancer, HIFU, ESWL, Urology, Therapeutic Ultrasound, Urinary stones, and Research & Development
|
Open
|
4 Rue du Dauphine
|
Vaulx-en-Velin
|
Auvergne-Rhône-Alpes
|
FR
|
69120
|
|
EDAP TMS
|
Health Care
|
Health Care Equipment & Services
|